Novartis AG (NVS)

88.12 +0.32  +0.36% NYSE Jul 8, 20:00 Delayed 2m USD

Novartis Gross Profit Margin (Quarterly):

70.71% for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Gross Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Gross Profit Margin (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 70.71%
Dec. 31, 2019 68.61%
Sept. 30, 2019 69.75%
June 30, 2019 71.67%
March 31, 2019 71.62%
Dec. 31, 2018 66.06%
Sept. 30, 2018 69.59%
June 30, 2018 69.47%
March 31, 2018 69.09%
Dec. 31, 2017 85.28%
Sept. 30, 2017 65.94%
June 30, 2017 65.92%
March 31, 2017 65.17%
Dec. 31, 2016 64.39%
Sept. 30, 2016 64.61%
June 30, 2016 64.89%
March 31, 2016 64.34%
Dec. 31, 2015 64.47%
Sept. 30, 2015 64.85%
June 30, 2015 65.21%
March 31, 2015 67.38%
Dec. 31, 2014 66.93%
Sept. 30, 2014 66.76%
June 30, 2014 68.61%
March 31, 2014 68.31%
   
Dec. 31, 2013 67.51%
Sept. 30, 2013 68.03%
June 30, 2013 69.22%
March 31, 2013 67.58%
Dec. 31, 2012 76.82%
Sept. 30, 2012 67.41%
June 30, 2012 68.30%
March 31, 2012 67.77%
Dec. 31, 2011 65.87%
Sept. 30, 2011 68.15%
June 30, 2011 69.46%
March 31, 2011 68.65%
Dec. 31, 2010 68.72%
Sept. 30, 2010 71.44%
June 30, 2010 73.11%
March 31, 2010 74.94%
Dec. 31, 2009 72.10%
Sept. 30, 2009 72.52%
June 30, 2009 73.71%
March 31, 2009 71.71%
Dec. 31, 2008 72.61%
Sept. 30, 2008 72.61%
June 30, 2008 73.28%
March 31, 2008 74.08%
Dec. 31, 2007 67.59%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Benchmarks

Benchmarks
AstraZeneca PLC 77.65%
Gilead Sciences Inc 82.53%
Johnson & Johnson 65.87%

Gross Profit Margin (Quarterly) Range, Past 5 Years

Minimum 64.34% Mar 2016
Maximum 85.28% Dec 2017
Average 68.23%
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.